Powikłania leczenia interferonem pegylowanym i rybawiryna u pacjentki z marskościa zółciowa watroby i nadkazeniem HCV.

Pawłowska, Joanna;Sokal, Etienne;Jankowska, Irena;Teisseyre, Mikołaj;Socha, Jerzy;et.al.
(2005) Przeglad Epidemiologiczny — Vol. 59, n° 2, p. 605-609 (2005)

Files

No attached file found for this publication.

Details

Authors
  • Pawłowska, Joanna
    Author
  • Sokal, EtienneUCLouvain
    Author
  • Jankowska, Irena
    Author
  • Teisseyre, Mikołaj
    Author
  • Socha, Jerzy
    Author
Show more
Abstract
Authors present a case of 15-years old girl with liver cirrhosis due to biliary atresia with HCV coinfection with portal hypertension after several episodes of variceal bleeding treated primarily with sclerotherapy and later with transjugular intrahepatic porto-systemic stent shunt. In a patient during the combined peginterferon alfa-2b and ribavirin treatment a decompensation of liver occurred with necessity for liver transplantation.
Affiliations

Citations

Pawłowska, J., Sokal, E., Jankowska, I., Teisseyre, M., Rokitka, M., & Socha, J. (2005). Powikłania leczenia interferonem pegylowanym i rybawiryna u pacjentki z marskościa zółciowa watroby i nadkazeniem HCV. Przeglad Epidemiologiczny, 59(2), 605-609. https://hdl.handle.net/2078.5/130121 (Original work published 2005)